Versant Ventures Strengthens Biotechnology Investment Team In North America And Europe

With a continued emphasis on a global approach to investing, Versant Ventures, an innovative healthcare investment firm, made key announcements today regarding its team. Dr. Tom Woiwode becomes Managing Director, and Drs. Guido Magni, Gianni Gromo, and Jerel Davis have been named Partners. The announcements come concurrent with the closing of the firm’s latest $305 million fund -- Versant Venture Capital V L.P.

Help employers find you! Check out all the jobs and post your resume.